Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2013
04/10/2013CN101392242B Alpha-glucosidase, gene thereof, preparation method, vector and host cell
04/10/2013CN101381722B Method for improving streptomyces bambergiensis bambermycin yield and bacterial strain
04/10/2013CN101319010B Novel scavenger receptor
04/10/2013CN101285057B EPSP synthase of high resistant glyphosate and coding sequence thereof
04/10/2013CN101198694B I-CreI meganuclease variants with modified specificity, method of preparation and uses thereof
04/10/2013CN101151367B Methods of refolding mammalian glycosyltranferases
04/10/2013CN101109012B Representation of vampire plasmin activator alpha 2 in yeast and manufacturing method thereof
04/09/2013US8415545 Maize variety inbred PHEMW
04/09/2013US8415544 Maize variety inbred PHNDE
04/09/2013US8415542 Plants and seeds of hybrid corn variety CH956667
04/09/2013US8415541 Plants and seeds of hybrid corn variety CH467170
04/09/2013US8415535 Soybean cultivar 07115150
04/09/2013US8415534 Soybean variety XB07Y11
04/09/2013US8415533 Soybean variety A1024631
04/09/2013US8415532 Soybean variety A1024630
04/09/2013US8415531 Soybean variety A1024629
04/09/2013US8415530 Soybean variety A1024626
04/09/2013US8415529 Pea line DLSC7V0955
04/09/2013US8415528 Pea line EX 08570956
04/09/2013US8415527 DNA constructs and methods to enhance the production of commercially viable transgenic plants
04/09/2013US8415526 Down-regulation of gene expression using artificial microRNAs
04/09/2013US8415525 Circovirus sequences associated with piglet weight loss disease (PWD)
04/09/2013US8415465 Compositions and their uses directed to huntingtin
04/09/2013US8415464 Chromosome-specific staining to detect genetic rearrangements
04/09/2013US8415463 Potexvirus-derived replicon
04/09/2013US8415462 Signaling peptides
04/09/2013US8415458 Modified vitamin K-dependent polypeptides
04/09/2013US8415457 Modified vitamin K-dependent polypeptides
04/09/2013US8415320 Delivery of dsRNA to arthropods
04/09/2013US8415319 Devices, systems and methods for improving memory and/or cognitive function through brain delivery of siRNA
04/09/2013US8415318 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
04/09/2013US8415317 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
04/09/2013US8415316 Method for increasing bone mass
04/09/2013US8415315 Methods and compositions for inhibiting the proliferation of cancer cells
04/09/2013US8415314 Methods for treating multiple sclerosis using antisense oligonucleotides
04/09/2013US8415313 Antisense oligomers and methods for inducing immune tolerance and immunosuppression
04/09/2013US8415306 Insulin-like growth factor 1 receptor binding peptides
04/09/2013US8415303 Method of treatment using a soluble human delta protein fragment
04/09/2013US8415160 Transfection with micro explosion enacted by coated dry ice particles
04/09/2013US8415148 Expression system
04/09/2013US8415147 Closterovirus vectors and methods
04/09/2013US8415146 Plasmid comprising two restriction recognition sequences different in nucleotide sequence for use as tool in heterologous gene expression; improving exogenous transcription vehicles
04/09/2013US8415129 Nucleic acid modifying enzymes
04/09/2013US8415127 Ketoreductases and uses thereof
04/09/2013US8415126 Polynucleotides encoding recombinant ketoreductase polypeptides
04/09/2013US8415123 Electromagnetic treatment apparatus and method for angiogenesis modulation of living tissues and cells
04/09/2013US8415120 Phosphate limited inducible promoter and a Bacillus expression system
04/09/2013US8415118 Porcine DC-SIGN, ICAM-3 and LSECtin and uses thereof
04/09/2013US8415101 Digital optical chemistry micromirror imager
04/09/2013US8415098 Method for isolating specific genomic regions
04/09/2013US8415097 Tumor suppressor gene, p47ING3
04/09/2013US8414903 Escherichia coli mutants and methods of use thereof
04/09/2013US8414900 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
04/09/2013US8414898 Serpentine transmembrane antigens expressed in human cancers and uses thereof
04/09/2013US8414895 Tweak receptor
04/09/2013US8414894 Human antibodies that bind human TNFα and methods of using same
04/09/2013US8414893 Anti-amyloid antibodies and uses thereof
04/09/2013US8414890 Human antibodies to human RANKL, encoding nucleic acids and methods of treatment
04/09/2013CA2680739C Method for evaluation of tissue preservation solution
04/09/2013CA2567267C Maize multidrug resistance-associated protein polynucleotides and methods of use
04/09/2013CA2546406C Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer
04/09/2013CA2490195C A non-blended soybean oil with high oleic acid content
04/09/2013CA2483483C Process for preparing oligonucleotides
04/09/2013CA2481414C Promoter and plasmid system for genetic engineering
04/09/2013CA2472206C Proteases producing an altered immunogenic response and methods of making and using the same
04/09/2013CA2471148C Methods for producing hyaluronan in a recombinant host cell
04/09/2013CA2455237C Compositions and methods for generating chimeric heteromultimers
04/09/2013CA2425208C Rna aptamers and methods for identifying the same
04/09/2013CA2421963C Directed evolution method
04/09/2013CA2391739C Site-directed mutagenesis of escherichia coli phytase
04/09/2013CA2370616C Nucleic acid sequences to proteins involved in isoprenoid synthesis
04/09/2013CA2360549C Double nuclear transfer method and results thereof
04/09/2013CA2359803C Udp-glucose epimerases
04/09/2013CA2325341C Mutagenized il13-based chimeric molecules
04/09/2013CA2288430C Crsp protein (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor
04/09/2013CA2274319C Methods and compositions for polypeptide engineering
04/09/2013CA2241373C Compositions and methods for t-cell activation comprising gm-csf and tumor antigen fusion proteins
04/09/2013CA2224176C Gene transfer for treating a connective tissue of a mammalian host
04/05/2013CA2758821A1 Compositions, methods and kits to detect adenovirus nucleic acids
04/04/2013WO2013049504A1 Dna sample preparation and sequencing
04/04/2013WO2013049493A1 Inducible adeno -associated virus vector mediated transgene ablation system
04/04/2013WO2013049389A1 Compositions and methods for transient expression of recombinant rna
04/04/2013WO2013049330A1 Synthetic transcriptional control elements and methods of generating and using such elements
04/04/2013WO2013049254A1 Hybrid constant regions
04/04/2013WO2013049005A1 Double stranded rna constructs to control ants
04/04/2013WO2013048734A1 Treatment and prevention of cardiovascular disease with cell derived lipid vesicles, microvesicles and exosomes
04/04/2013WO2013048661A1 Fungal proteases
04/04/2013WO2013048345A1 Methods and pharmaceutical compositions for treating cancer
04/04/2013WO2013048255A2 Heat tolerance microrna
04/04/2013WO2013048254A1 Heat tolerance microrna
04/04/2013WO2013047912A1 Method for evaluating drug sensitivity and susceptibility to diseases by analyzing gene for protein capable of binding to cyclic-amp-responsive sequence
04/04/2013WO2013047910A1 Method for evaluating degree of cancerization
04/04/2013WO2013047844A1 Ngf aptamer and application thereof
04/04/2013WO2013047815A1 Endoplasmic reticulum stress regulator
04/04/2013WO2013047785A1 Method for detecting protein that interacts with target substance
04/04/2013WO2013047767A1 Novel amidase
04/04/2013WO2013047752A1 Antigen-binding molecule for promoting loss of antigens
04/04/2013WO2013047748A1 Antigen-binding molecule promoting disappearance of antigens having plurality of biological activities
04/04/2013WO2013047736A1 Nucleic acid encoding self-incompatibility regulation factor
04/04/2013WO2013047729A1 Antigen-binding molecule inducing immune response to target antigen